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INTRODUCTION 
 
Infrainguinal bypass surgery in Chronic Limb Ischemia is the mainstay of 
therapeutic interventions aimed at limb salvage. The outcome of surgery is the chief 
determinant of limb salvage and is affected by many factors which can be modifiable 
factors (Smoking, Obesity, Hypertension, Lipids,  Glycaemic control) and non modifiable 
factors (Age, Gender, Ethnicity, Family history). Since 1949, when Kunlin introduced the 
femoropopliteal bypass graft with saphenous vein, several centers have reported their 
results. Patency rates at 30 days have varied from 76% to 96%1. Cumulative five-year 
patency has varied from 60% to 76%.  
Arterial disease of the lower limbs includes conditions such as inflammatory 
arteritis, TAO, vasospastic disorders and medial calcification. However, by far the 
commonest cause of Peripheral Arterial Occlusive Disease (PAOD) is Atherosclerosis 
which consists of slow accumulation of lipids and fibrosis in the arterial intima. The 
interaction between environmental and genetic factors accentuates the development and 
progression of occlusive vascular disease, involving one or more major vessels of the 
lower limb with an increased risk of acute limb threatening or life threatening ischemia.     
Patients in our population present with characteristic features of TAO in addition that 
they have occlusive disease in the medium and larger sized arteries including the femoral 
and iliac arteries. The incidence of disease in these proximal vessels seems to be 
particularly high in our population, contrary to disease definitions elsewhere in the world. 
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Arterial reconstruction especially with infrainguinal grafts for peripheral arterial 
occlusive disease continues to provide a significant challenge for vascular surgeons.  
Graft surveillance refers to periodic evaluation of the grafts by means of tests that 
may involve special instrumentation, by which an abnormal result, suggest, the presence 
of pathology .By graft surveillance,  failing grafts  can be identified and corrective 
measures  can be taken at appropriate  time to improve graft patency. 
Evaluation of patients with infrainguinal grafts has clearly demonstrated the 
factors that will affect the long term patency of vascular conduits .The patency of 
vascular grafts mandates a protocol of postoperative surveillance to identify grafts at risk 
of thrombosis since bypass graft occlusion is associated with significantly morbidity and 
limb loss. The correction of lesions before graft thrombosis can have a significant impact 
on long term patency. Analysis of the intensity of post-operative non-invasive 
surveillance, and their efficacy will be reviewed. .  The patency rates have been related to 
clinical severity of ischemia, run-off, diabetes and diameter of vein. 
The diameter of the stenosis, therefore, is far more important than its length. 
When the lesion responsible for a stenosis is axi-symmetric, a 75% area reduction 
corresponds to a 50% diameter reduction. Stenoses of this magnitude seen on 
arteriography are frequently labeled “critical” or “hemodynamically significant.” In order 
to clarify the natural history of graft failure ,the importance of graft surveillance has  
inspired me  to conduct this study   
 Factors vary depending on the interval in the follow-up period and factors 
adversely affecting 30 day patency are primarily technical in nature and are related to 
3 
 
surgical technique. Such factors are best prevented and can often be identified by 
intraoperative evaluation. In the time period between 1 month and 12 months fibrointimal 
hyperplasia in a variety of forms is the primary cause of graft failure.  Beyond  12 months 
the disease progression in both the inflow and outflow vessels and the conduit 
degenerative changes results in graft failure. 
This study is planned to review the factors that will influence the outcome of  
infrainguinal bypass in CLI  and to identify those factors that are modifiable, which will 
help in improving the outcome of the procedures and improve the patency of the graft 
and limb salvage rate.  
Efficacy of post-operative medical therapy is also reviewed. 
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AIM 
 
 To analyse the outcome of infra-inguinal arterial revascularisation procedures.    
 To study the influence of risk factors.  
 To identify failing graft.  
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
MATERIALS AND METHODS 
 
 Prospective study 
 
 Study period:    January 2010 to January 2012  in  56 patients 
 
 Patients selection  : 
 
Case records of all patients admitted with the clinical diagnos is of for critical 
lower limb ischemia and severe disabling claudication who underwent femoropopliteal 
bypass procedures and tibial artery bypass procedures were analysed .  
All patients were evaluated with  proper clinical history, physical examination and  
pre operative   CT angiogram  was performed in all patients to assess the occlusive 
pattern and fiow limiting lesions, status of femoral ,popliteal artery and distal arteries run 
off status and the lesions were classified as per  TASC 2007 classification. All patients 
with TASC C and D lesions and few selected patients with TASC B lesions were 
enrolled.                             
 
              
. 
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 TASC A- Lt (Small segment stenosis of the mid SFA).                                               
 
        
 
 
 
 TASC B-(Occlusion > 5cm in the distal SFA extending into the P1 segment). 
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TASC C- Lt (Occlusion of SFA >15cm and <20cm). 
 
 
 
 
 
             TASC D- Lt (Occlusion of SFA >20cm). 
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 Inclusion criteria : 
Patients who underwent infrainguinal bypass surgery for CLI 
and      incapicitating  claudication  
 Exclusion criteria :  
- Infrainguinal bypass done as part of sequential     bypass with 
proximal  outflow disease correction 
- Patients  not undergone any earlier infrainguinal vascular 
procedures 
- Acute limb ischemia 
- Trauma 
 Factors studied  : 
- Age and sex distribution 
- Etiology –Atherosclerosis / Thromboangiitis obliterans / 
Arteritis  /  Smoking 
- Clinical presentation – critical limb ischemia /extent of tissue 
loss /   severity of claudication  /  Pre  and post operative ABI 
/clinical level of occlusion  CT angiogram details 
- Co morbid factors – diseases such as Diabetes Mellitus / 
Systemic Hypertension / Coronary Artery Disease / CVA / 
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history of tobacco abuse/ CKD/CRP levels/ Hyperlipedimia  
/hypothyroid  etc 
- Operative details— level of revascularization, conduit used, 
post operative vessel status 
-  Graft patency 
- Clinical categoric improvement  and  limb Salvage  
 Etiology  :  
Patients were categorized according to the etiological factors as 
- Atherosclerotic obliterans 
Inflammatory arteritis,vasospastic disorders and medial 
calcification  are some of arterial diseases of the lower limbs  . 
However, by far the commonest cause of peripheral arterial disease 
is Atherosclerosis consisting of slow accumulation of lipids and 
fibrosis in the arterial intima. 
- Thrombo angitis oblierans   -  Shionoya's criteria 
 Less than 50 years age at  onset 
 Smoking 
 Infrapopliteal lesion 
 Upper limb lesion 
 Phlebitis migrans  
 Absence of  ASO risk factors 
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- Arteritis  - raised CRP   
- Hypercoagulable state        
 
 Treatment of Chroniic Critical  Limb  Ischemia 
1. Endovascular intervention: The optimum lesion for PTA (Percutaneous 
transluminal angioplasty) are short stenosis or occlusions of the  iliac and the 
proximal SFA with good run off. 
     2. Surgery: For long occlusion and infrainguinal lesion endovascular treatment 
is more complex and if intervention is required then bypass surgery gives better 
results 
    3. Non-interventional management: In about 10% of patients ,it will be 
technically impossible to revascularise th limb.Several pharmacological agents 
have been tried and the most promising are prostanoids, particularly 
prostacyclin.Iloprost ,a stable prostacyclin analogue , has reduced the amputation 
and death.In some patients the limb survives , but pain remains a problem.If 
simple analgesia is inadequate then Lumbar sympathectomy either chemical or 
surgical may be helpful.In this study only patients who underwent bypass surgery 
were enrolled. 
 Indication for bypass :  
 Critical limb ischemia 
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Patients develop severe claudication symptoms after a few steps and walking is  
impossible even in the absence of gangrene, ulceration / tissue loss, or rest pain.       
            Incapacitating claudication 
European Consensus Document defines CLI as persistent, recurring 
ischemic pain requiring opiate analgesia for at least 2 weeks and ankle systolic 
pressure lower than 50 mmHg and or toe systolic pressure lower than 30 mmHg; 
or ulceration or gangrene of the foot or toes. 
Critical limb ischemia is often fatal if untreated, but even after arterial 
reconstruction or amputation, 40-75% of patients will die within 5 years of 
presentation mainly due to cardiac problems. 
 
 Anatomical Level of Revascularization: 
Categorized according to the level of occlusion and analyzed for the type of 
revascularization as follows 
- Femoral- Proximal Popliteal  Artery 
- Femoral-   Distal Popliteal  Artery 
- Femoral-   Anterior Tibial  Artery 
- Femoral-    posterior Tibial Artery  
- Femoral-   TP Trunk 
Compliance mismatch and to reduce shear stress while performing distal bypass 
anastomosis  by creating anastomotic vein cuff or vein patch ( Millers cuff,  Lintons 
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patch, Taylors patch and St Marys Boot )  in case of prosthetic graft placement. Topical 
papavarine and intraoperative Dextran infusion 15 ml/hour, continued in postoperative 
period for 48 hours if cardiac function is good.       
 Graft characteristics : 
 Autologous vein 
 Synthetic   graft 
 Composite graft 
 
 Outcome reporting : 
Various outcomes can be used in the measurement after treatment including graft 
patency,  limb  salvage, clinical status, and quality of life.  
 Following revascularization a sustained rise of > 0.15 of ABI was taken to 
indicate a successful bypass (Normal ABI is > 0.97) and the clinical change is 
gauged after revascularization. 
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Scale for gauging change in clinical status 
+3 Markedly 
improved 
No ischemic symptoms, and any foot lesions completely 
healed; ABI essentially” normalized" (increased to more 
than 0.90) 
+2 Moderately 
improved 
No open foot lesions; still symptomatic but only with 
exercise and improved by at least one category; 
ABI not normalized but increased by more than 0.10 
+1 Minimally 
improved 
Greater than 0.10 increase in ABI" but no categorical 
improvement or vice versa (i.e., upward categorical 
shift without an increase in ABI of more than 0.10 ) 
0 No change: 
 
No categorical shift and less than 0.10 change in ABI 
-1 Mildly worse 
 
No categorical shift but ABI decreased more than 0.10, or 
downward categorical shift with ABI decrease less than 0.10 
-2 Moderately worse One category worse or unexpected minor amputation 
-3 Markedly worse More than one category worse or unexpected major 
amputations 
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The above said method of reporting system was followed in this study to follow 
uniformity in the reporting standard. In this method of reporting a combination of the 
clinical method and segmental pressure index were used to assess the patient’s clinical 
improvement or deterioration. This categorizing of the result is useful in grading of the 
outcome in the same way for all the patients and useful in assessing clinical success in the 
follow up period.  
Post operative details -- 
 Category improvement 
 Rest pain relief 
 Ulcer healing 
 Improvement Ankle brachial index 
 Wound complications 
 Further interventions, if any 
 
 Graft surveillance  methods 
Graft surveillance was done by symptomatic analysis of rest pain status, 
claudication status, palpable popliteal pulse and distal pulses, ABI   determination,  Shape  
of  doppler waveform in duplex scan and if needed by  CT Angiogram 
Clinical examination -- of Rest pain status, Claudication status, Pulse 
status like palpable femoral, popliteal and distal pulses examination with 
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handheld Doppler and Duplex scan for failing signals and with post operative 
ABI. 
ABI   determination -- using hand held continuous wave Doppler 
ABI is   calculated by measuring highest systolic ankle pressure divided by the 
brachial systolic pressure. Brachial pressure is taken as standardization because it 
corresponds well with aortic and femoral pressure. Diastolic pressure does not fall 
until the stenosis is quite severe and hence systolic pressure is sensitive. 
 Duplex scan-- is highly sensitive and specific for identifying lesion that 
threatens the graft patency. Combination of B-Mode real-time anatomic imaging 
and Doppler spectral wave analysis with measurement of flow and velocity. 
Duplex scan identifies failing graft which is defined as hemodynamic 
disturbances without thrombosis. Color flow image rapidly identifies the region 
with high velocity or disturbed flow. Duplex criteria for normal flow in graft is 
PSV less than 125cm/sec & velocity ratio of 1:1.4 
 First duplex scan screening was done at operation theatre if needed, if not 
prior to discharge from hospital. The pre discharge duplex examination permits 
identification of bypass which are prone to progress, which if it occurs and is 
corrected in timely fashion dramatically reduce the incidence of thrombosis 
within first year of bypass surgery. 
When a graft develops a low flow state, attention should be directed to 
possible causes a) Loss of inflow b) Outflow impediment c) Critical graft stenosis 
creating an impediment of flow. 
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Shape of Doppler waveform is important in early postoperative period, as 
grafts have a continuous antegrade flow during the cardiac cycle. This is thought 
to be secondary to the chronic vasodilatation which is caused by the baseline 
peripheral arterial lesions that have bypassed. As vascular tone is regained over 
time the waveform becomes triphasic .Conversion from a triphasic to a 
monophasic waveform with decreased PSV is suggestive of a remote occlusive 
lesion. A pre occlusive staccato signal portends a poor prognosis and is indicative 
of high grade stenosis in the distal graft. 
Flow patterns in duplex scanning-- Forward flow due to stenosis and low 
peripheral resistance (capiilaries open which is normal only after exercise and not 
in stenosis / obstruction) is known asMonophasic flow.  Distal to severe arterial 
obstruction due to slowed systolic acceleration & increased diastolic flow is 
known as Dampened flow.  Highest end diastolic velocity means  diameter 
reduction (DR) will be normal till 50% .It will be elevated in 50-70 % DR to  
>100cm/s   
CT Angiogram -- Site of occlusion, distal reformation, Angiographic 
runoff score and to delineate   future planning like revision procedure if needed     
All patients were followed at 1st month from the day of surgery and at end 
of 12th month. Patients who had a decrease in the ABI of 0.15 as compared to the 
discharge values or CDFI evidence of PSV>180cm/ sec or <30cm/ sec will be 
considered as have failing graft and were taken up for angiography if it is 
necessary for  post operative evaluation   
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 Showing grey scale appearance of the graft. 
 
 
 
 
 CDFI of a patent graft and its flow pattern. 
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 Graft patency rates were calculated for 1, 3, 6, and 12 months. 
1. A graft was considered to have primary patency as long as the patency was uninterrupted 
(was defined as the period between the initial bypass operations till the graft occlusion).  
2. Primary assisted patency was defined as any interventions preserving the patency of the 
failing graft (patent graft with PSV > 180cm/s or < 30cm/s, ABI < 0.15 from the previous 
values).  
3. When the graft patency was restored successfully (after graft occlusion), it was recorded 
as secondary patency. Secondary patency lasted until the graft was permanently 
occluded. 
Graft patency rates were calculated with respect to the run off status and also with respect 
to the graft size and smoking status of the patients. Secondary patency is restored after 
occlusion by any of the following procedures  
- Fogarty and  adherent clot catheter  were used for-- graft  thrombectomy  
- Short segmental stenosis <1.5cm--   Balloon  
- Angioplasty. 
- Long stenosis >4cm--Interposistion graft 
- Short focal stenosis (<4cm)-- Patch plasty 
- Thrombolysis-- using systemic or regional Heparin 
- Long segment stenosis that involving  anastomotic site  --Jump graft  
- Transposition graft --connecting the bypass to different vessel target 
- For diffuse intimal hyperplasia with narrowed caliber --New graft 
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 Pre  Operative  Evaluation  
Duplex Scan - The Duplex scan is specific for identifying lesion that threatens the 
graft patencyand hemodynamic disturbances in the graft. Color flow image rapidly 
identifies the region with high velocity or disturbed flow. 
     Hand Doppler- continues wave Doppler 
Anesthetic assessment was done and the risk categorization was done as per 
Goldman risk categorization method, taking into the investigation of the individual 
patient. Most of the patient underwent surgery under regional anesthesia with the intent to 
have post operative pain relieving by continuous epidural anesthesia. These patients also 
had spinal anesthesia along with epidural anesthesia. 
 
 Operative  Technique 
Patients were given third generation cephalosporins (for gram + ve bacteria) and renal 
adjusted does of amino glycosides (for gram – ve bacteria) and metronidazole in selected 
patients 30 minutes before the operation to prevent surgical site infection.  Patients were 
subjected to femoro-popliteal or femoro-tibial bypass grafting (in addition to the adjuvant 
inflow and out flow procedures as required) with GA, Spinal,  epidural anesthesia. RGSV 
or prosthetic graft (e PTFE) of suitable size was used.  
After exposing the vessels, all patients were given IV heparin (100 IU/ Kg body 
weight and not more than 5000 IU) and was repeated 1000 IU every hourly if the 
duration of the surgery was more than 1 hour. During the surgery, popliteal artery 
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was first exposed by medial approach and its patency was confirmed by getting 
good back bleed. If required endarterectomy of the popliteal artery was done to 
establish good back bleed. Routine insertion of Fogarty catheter into the distal 
vessels to assess the patency was not done. Heparin saline was then infused into 
the distal vessels by an infant feeding tube kept inside the popliteal artery. Then 
femoral artery was exposed by vertical groin incision and good antegrade flow 
was confirmed. Distal AV fistula to enhance the graft patency was not done in 
any of the cases. None of the patients required protamine for reversal of the effect 
of heparin. Postoperatively all patients were given plain heparin or  LMWH for 5 
days & Tab. Aspirin 150mg OD & Tab. Clopidogrel 75mg OD was started once 
the drains were removed and continued till lifelong. Along with these drugs, Tab. 
Atorvastatin 20mg HS was given to all patients and other drugs as per their co-
morbidities.  
 
 outcome 
                         Limb salvaged / major amputation/ minor amputation 
 
 discharge status 
 
• follow up- 1,3,6, and 12 months 
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The initial evaluation of the patients starts prior to discharge or within one month 
after    implantation, followed by on 3 months,6 months and 12  months  .  
All the patients were recommended aspirin or clopidogrel and, statin in ASO groups, 
postoperatively to decrease graft occlusion as well as for its cardio protective effects 
and in high risk group, if needed, long term anticoagulation like Tab .Acitrom was 
advised. 
 
• Statistical analysis was done to compare mainly the graft patency rates with respect 
to the run off status and also with respect to the graft type (RSV or PTFE ) , smoking 
status etc  as they  independent predictors of the graft patency. 
P value was calculated by using Chi- Square test to establish the statistical 
significance. P value  of < 0.05 was considered as statistically significant . 
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REVIEW OF LITERATURE 
The peripheral arterial occlusive disease of femoro popliteal segment is one of the commonest 
arterial lesions of the lower extremity, especially in patients over 60 (Text book of vascular & 
endovascular surgery By Jonathan D Beard) (25). The clinical manifestations of arterial lesions  
vary with their location and extent, as well as the degree of associated vascular lesions. They are 
divided in 3 major groups of increasing severity. (Intermittent claudication, Ischemic Rest pain 
and gangrene) Graft thrombosis in the early postoperative period represents a failure for both 
patient and surgeon. The causes for the graft failure involve both patient factors and technical 
factors. It is believed technical errors at the time of operation account for early failures and some 
cases of late failure in long follow up, and there is general agreement that technical factors 
account at least for early failures. The patency rates have been related to clinical severity of 
ischemia, run-off, diabetes and diameter of vein. 
 Introduction of thrombo-endarterectomy by J.CID.DOS SANTOS in 1947 and by pan grafting 
technique by Kunlin in 1940 marked the beginnings of the direct revascularization methods of 
the lower extremity (Vascular surgery principles & techniques- By Haimovici) (26). Evaluation of 
these operations is centered on the early and long-term results as they relate to a number of 
factors like selection of patients with regard to functional improvements or limit salvage, type of 
reconstruction, the grafting material, associated diabetes mellitus,  influence the results of lower 
extremity arterial reconstruction. 
The ACC/AHA guidelines suggest that the risk of major limb amputation for a patient with 
intermittent claudication is approximately 1% per year, whereas the risk of cardiac death is  
approximately 3% to 5% per year (29) (Am J Surg 1976) . Treatment strategies have therefore 
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stressed cardiovascular risk factor modification and medical therapy as the best initial treatment 
for patients with PAD symptoms limited to intermittent claudication. Revascularization is  
recommended only in cases of severe claudication, and only after medical therapy has failed. 
 Pharmacotherapy for CLI has failed to yield any breakthrough therapy. The routine use of 
modern wound care methods such as negative-pressure wound therapy, intense debridement, and 
antibiotic therapy, prostanoids, vasodilators, antiplatelet agents, and even hyperbaric oxygen for 
the treatment of ischemic ulcers remains of unproven benefit (30). Thus revascularization is an 
essential component in the relief of CLI. 
In January 2000, the Trans-Atlantic Inter-Society Consensus for the Management of Peripheral 
Arterial Disease (TASC) published a document authored by a working group of representatives 
from 14 surgical vascular, cardiovascular, and radiologic societies (28). An upgraded document 
(TASC II) was published in January 2007. (27). (28) (J Vasc Surg. 2007; 45-Suppl) 
 
Management of lower extremity peripheral arterial disease according to TASC II (28) 
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Endovascular Treatment versus Open Surgery: 
Diffuse, extensive PAD causing CLI in femoropoplital locations are best treated by surgical 
bypass according to TASC. Open surgery is usually associated with higher perioperative 
morbidity and longer hospitalization (Eur J Vasc Endovasc Surg) 2005 (31). Expensive and 
tedious long-term postoperative graft surveillance is necessary to maintain a patent infrainguinal 
bypass suggest that such surveillance is economically justified by preventing graft occlusion and 
late amputation. A re-intervention rate of 20% to 30% to treat failing grafts due to intrinsic graft 
stenosis is usually necessary to maintain the increased durability attributed to open surgery. 
Those who favor interventional treatment cite the low morbidity and mortality associated with a 
procedure that is usually performed on an outpatient basis (32). Though proponents acknowledge 
the limited reconstruction patency rates associated with interventional treatment, especially for 
the high-risk lesions often encountered in CLI, they argue that restenosis rarely jeopardizes 
subsequent surgery (32) (Eur J Vasc Endovasc Surg) 2003).  
Choice of the conduit: 
Kunlin's first description of the successful use of autogenous vein to bypass femoro popliteal 
arteriosclerosis obliterans, there is near universal agreement that autogenous vein is the best 
conduit for infrainguinal bypass at all levels( J Vasc Surg 1990; 11:193-205) (33). The great 
saphenous vein (GSV) is the most readily available and durable conduit. Ipsilateral small 
saphenous vein, the contralateral great and small saphenous veins, and the upper extremity veins 
are the alternatives in the order of preference.  Assessment of vein availability and quality is 
critical and should be carried out before embarking on the operation. Cryopreserved vein grafts 
are expensive and have not performed well in clinical practice (34); they may serve a niche role 
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when revascularization is required following the removal of an infected bypass graft and 
autogenous vein is unavailable to create a new bypass through clean tissue planes( J Vasc Surg )  
(34). 
One of the most  prosthetic  infrainguinal bypass conduits is ePTFE. Studies suggest that 
biologically active heparin has been successfully covalently bonded to ePTFE without causing 
systemic anticoagulative effects (35) has  improved prosthetic graft patency in humans(J Vasc 
Surg 2006). 
For bypasses that insert below the knee, the addition of a vein cuff confers a significant patency 
advantage (52% patency at 2 years for PTFE with vein cuff versus 29% for PTFE with no cuff) 
and also improves limb salvage (84% versus 62%; P < .03) (20).  
Out comes of femoro popliteal bypass: 
Graft patency, limb salvage, and mortality are objective endpoints. Subjective endpoints are 
functional outcome and quality of life. Nicoloff and coworkers emphasized that an ideal 
outcome—defined by the expectations of a patent graft, healed wound, no need for reoperation, 
independent living status, and continued ambulation. Only a small fraction of patients in their 
report (14.3%) met these basic criteria for success. Abou-Zamzam and colleagues identified 
preoperative independence and ambulation as the best predictors of postoperative independence 
and continued ambulation (63). These data emphasize the severity of underlying co-morbidities in 
CLI patients and the difficulties encountered in obtaining functional limb salvage. Prospective 
trials (PREVENT III [Prevention of Recurrent Venous Thromboembolism] and BASIL [Bypass 
versus Angioplasty in Severe Ischemia of the Leg]), support  regarding the effectiveness of leg 
bypass in relieving ischemic symptoms and improving quality of life (QoL) in properly selected 
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patients. Patients with true CLI have a markedly reduced QoL compared with a normal control 
population and their QoL is markedly improved by successful bypass (37). It is also becoming 
evident, especially in CLI patients, that ongoing graft patency, at least for the first 1 to 2 years, is 
critical to the maintenance of this QoL improvement (38). 
Female gender is frequently cited as a factor that negatively influences the outcome of open or 
endovascular reconstruction. One reason is the inflow and outflow vessels, are typically smaller 
in women.Endovascular treatment(ET) for infrainguinal disease, preliminary results suggest a 
trend toward improved outcomes following the treatment of femoro popliteal lesions compared 
with infrapopliteal lesions( Ann Surg 2007) (39). ET of stenotic lesions yields  better immediate 
and long-term outcomes than does the treatment of occluded lesions (40). 
As per a national survey by the Vascular Surgical Society of Great Britain and Ireland, around 
70% of patients with critical limb ischemia were offered some form of revascularization 
procedure, with a 75% chance of limb salvage. The overall amputation rate was 21.5% and 
mortality rate was 13.5% (43). In the NHANES study the following risk factors (and odds ratios) 
were significantly associated with PAD: black race/ ethnicity (OR- 2.83), current smoking status 
(OR- 4.46), diabetes (OR- 2.71), hypertension (OR- 1.75), hypercholesterolemia (OR- 1.68) and 
poor kidney function (OR- 2), elevated fibrinogen and C reactive protein levels (44).  There is 
clear evidence from several studies that increasing age is associated with an increased risk of 
PAD in both men and women (44). Cigarette smoking is associated with excess premature deaths 
from CVA, respiratory and cancer related diseases (46). Smoking is undoubtedly the most 
important modifiable risk factor for PAD. Smokers are more likely to progress to critical limb 
ischemia and more likely to require an amputation or vascular intervention. Smoking increases  
the overall mortality rate among claudicants by a factor of 1.5- 3.0 (45). 
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The Framingham and other related studies have provided good evidence that hypertension is a 
powerful predisposing factor for development of PAD. Up to 5% of hypertensive patients have 
been reported to have clinical evidence of PAD at presentation, with a marked age related 
increase in hypertension associated PAD (47). In the Rotterdam Study investigating determinants 
of PAD, after multivariate analysis each 10mmHg increase in systolic BP conferred an increased 
risk of PAD (OR 1.3, 95% CI 1.2- 1.5) (48). Effective antihypertensive therapy is likely to 
ameliorate the progression of PAD as well as reducing the mortality from stroke and coronary 
artery disease. The REACH (The Reduction of Atherothrombosis for Continued Health) registry 
confirmed that patients with atherosclerotic disease affecting several arterial territories had 
proportionately higher risk of a major CV event (48). 
A meta-analysis by the Antiplatelet Trialists’ Collaboration showed that antiplatelet therapy, 
mainly with low-dose aspirin, reduced the risk of non-fatal MI, non-fatal stroke and vascular 
death in high risk patients, including those with intermittent claudication (49). The CHARISMA 
trial was performed to assess the effects of dual antiplatelet therapy (aspirin + clopidogrel) in 
patients with more stable atherosclerotic disease (50). 
Endovascular Treatment and Recent Advances 
Endovascular treatment (ET) is increasingly the first option for treating infrainguinal peripheral 
arterial disease (PAD). Percutaneous transluminal angioplasty (PTA) with adjunctive stenting is 
a well-validated and increasingly used technology, and it is the technique most frequently 
employed for infrainguinal ET. An alternative to transluminal angioplasty is subintimal 
angioplasty (SIA), also referred to as percutaneous intentional extraluminal revascularization. 
SIA is used to cross occluded vascular lesions and recanalization is performed by intentionally 
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exiting the vascular lumen, entering the subintimal plane and then reentering the vascular lumen 
distal to the lesion. Stenting is an adjunctive procedure used either routinely or selectively for the 
treatment of complex lesions or persistent stenosis or to correct intraprocedural complications. 
The new TASC femoro popliteal criteria reflect the fact that increasingly complex disease can be 
managed using endovascular techniques. TASC type A lesions are suitable candidates for ET; 
TASC type D lesions necessitate surgery, owing to ET's prohibitive failure rate; and TASC types 
B and C lesions can be treated using either endovascular or surgical revascularization, depending 
on the clinical scenario. 
Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial was a multicenter 
randomized controlled trial that assigned 452 patients to a surgery-first or angioplasty-first 
approach (41). The primary endpoint was amputation-free survival,  and at 6 months’ follow-up, 
there was no significant difference in amputation-free survival between the two groups. Health-
related quality of life, as measured by the EuroQol 5-D and Short Form 36, did not differ 
significantly between the two groups. The minimally invasive nature of PTA, improvements in 
technology, and growing operator experience have increased the aggressiveness with which 
complex infrainguinal lesions are approached using ET.  
The modulation of growth factors to stimulate angiogenesis is an area of focus in the treatment of 
lower extremity PAD, particularly in patients who are not candidates for surgical or 
interventional techniques. Therapeutic angiogenesis is defined as the growth of new blood 
vessels from preexisting blood vessels to treat ischemic disease. The putative concept by which 
angiogenesis improves limb perfusion is the growth of new blood vessels and possible direct 
stimulation of wound healing by growth factors. 
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The Therapeutic Angiogenesis with Recombinant Fibroblast Growth Factor-2 for Intermittent 
Claudication (TRAFFIC) study was the first randomized clinical trial to show a positive effect of 
growth factor therapy in limb ischemia (51). The Therapeutic Angiogenesis Leg Ischemia Study 
for the Management of Arteriopathy and Nonhealing Ulcer (TALISMAN) trial demonstrated that 
intramuscular injection of FGF-1 resulted in a twofold decrease in major amputation compared 
with placebo (52).  
Stem cell therapy is another technique to induce therapeutic angiogenesis. This technique has 
used bone marrow mononuclear cells or endothelial progenitor cells obtained from bone marrow 
harvest or,  from circulating peripheral blood stem cells. Endothelial progenitor cells can be 
identified by cell sorting for CD34-positive, VEGF receptor-2–positive cells. Once concentrated, 
the cells can be injected into the ischemic limb to induce angiogenesis. Tateishi- Yuyama and 
coworkers, in a randomized prospective trial, showed that injection of bone marrow–derived 
mononuclear cell injections resulted in a significant increase in ABI and tcPO2 compared with 
controls (53). 
Multiple reports have clearly demonstrated improvements in pain free ambulation and overall 
walking performance with structured exercise training (54). Data from more than 20 randomized 
trials have confirmed that exercise therapy is the best initial treatment of intermittent 
claudication (54). Although exercise therapy appears to be easy to implement, effectiveness is 
often limited by poor patient compliance. Effective exercise training is not possible in up to 34% 
of patients because of co-morbid medical conditions and an additional 30% of patients simply 
refuse to participate in exercise training (55). 
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New TASC guidelines are set to recommend an endovascular first strategy even for TASC D 
lesions. As per the European perspective of TASC managements 2011 for femoro popliteal 
lesions, revascularization strategies should begin with endovascular approaches in TASC A, B, C 
and D lesions. Surgical revascularization should be reserved for endovascular failures, occlusion 
of profunda femoris artery (PFA), severe disease of CFA and PFA and occlusion of popliteal 
artery with concomitant infra popliteal disease. However TASC II b remains unpublished as  
vascular surgical societies have so far failed to endorse these recommendations. 
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CT Angiogram of SFA Occulision 
 
 
 
 
Common Femoral Artery exposure for Proximal Anestomosis 
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Parachuting  of  PTFE (Proximal Anestomosis) 
 
 
 
 
Exposure of Proximal Popliteal Artery for Distal Anestomosis 
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Distal Anestomosis of  PTFE to Popliteal Artery 
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                                             OBSERVATION AND RESULTS 
 
Review of   prospectively collected data was performed of fifty six patients who 
underwent peripheral arterial bypass procedures for lower limb ischemia due to various 
etiology was randomly selected and enrolled in this study, .Among them 53 were males 
(94.6 %) and 3 females (5.3 %) .  
             
 
   
                                                                                
      
 Sex Incidence 
 
 
male 
53 
95% 
female 
3 
5% 
male
female
Patients Frequency Percent 
 Male 53 94.6 
 Female 3 5.4 
 Total 56 100.0 
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The age varied between 29 yrs to 74 yrs. Most patients were in the age group 40 to 60 
years (60.5%). The mean age of patients was  51.57   years   
 Minimum Maximum Mean  Age  Std. Deviation 
Age in years N =56 26 74 51.57 10.731 
         
 
 
Age Group  Number  Percent 
20 – 29 2 3.5 
30 – 39 06 10.7 
40 – 49 14 25 
50 – 59 22 39.2 
60 – 69 07 12.5 
70 – 79 05 8.9 
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                                  TASC   Classification of  fem pop disease  in this study 
 
 
 
 
 
 
 
 
 
 
TASC D lesion was the most common lesion (72.5%) in this study, followed by 
25% in TASC C lesions and 2.5% in TASC B lesions ,  for which infra inquinal bypass 
was  performed . 
 
 
 
 
 
TASC A, 0% 
TASC B, 2.50% 
TASC C, 25% 
TASC D, 72.50% 
 TASC   Grouping   
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          Incidence  of  clinical presentation  
Clinical presentation Number Percent 
Toe gangrene 33 58.9 
Non healing ulcer 20  35.7 
Forefoot gangrene             04               7.1 
Rest Pain             07                 12.5 
 
 
       Critical limb ischemia was the most common cause for the surgical 
intervention. Minor tissue loss in the form of toe gangrene was the most common 
indication for revascularization (58.9  %). Non healing ulcers( 35.7 %),Rest pain(12.5%) 
and forefoot gangrene formed about (  7.1%)  of the patients.  
0 10 20 30 40
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Non healing ulcer
Forefoot gangrene
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 Clinical  Presentation 
 Number  of patients
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   Etiology statistics  
 
Etiology Number Percent 
ASO 38 67.8 
TAO 16 28.5 
Arteritis 2 3.57 
Total 56 100.0 
 
 
 
Etiological  Presentation 
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Out of the 56 patients who underwent bypass surgery for chronic limb ischemia, 
38(67.8 %)  patients were diagnosed to have Atherosclerotic Occlusive Disease, 16(28.5 
%)   patients were diagnosed to have Thromboangitis Obliterans as per the clinical 
criteria of Shinoya, and 2(3.5 %)  patients were diagnosed to have arteritis  forms the 
major proportion of the patients who underwent revascularization for Critical limb 
ischemia group. 
 
             Risk factors and associated co-morbidities 
 
               Risk Factors Number Percent 
Smoking and smokeless tobacco 47 83.9 
Diabetes mellitus 21 37.5 
Dyslipidemia 27 48.2 
Systemic hypertension 16 28.6 
CAD 10 17.9 
CKD 2 3.6 
CVA 1 1.8 
Atrial myxoma 1 1.8 
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                                                                    Risk factors 
 
 
 
 
In the study group of 56 patients, very few people had single risk factor but many 
had multiple risk factors. Among study group  ( n= 45) 83.9%  were smokers, ( n= 21) 
37.5% were diabetics, ( n= 27) 48.2 % were Dyslipidemia, ( n= 16) 28.6 % were 
hypertensive patients, ( n= 10) 17.9%  were ischemic heart disease patients and 
remaining  patients had other risk factors 1 patients had cerebrovascular accident, 2 
patient had chronic renal failure and 1  patient had Atrial Myxoma . Smoking history was 
present in 83.9%  of the patients, which was the single major risk factor in all the 
patients. 60% of diabetics were not on regular treatment. These diabetics’ patients who 
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had critical limb ischemia were diabetic for a prolonged period. The average period for 
DM  being minimum of 7 years.  
Most of them were bare foot walker or were wearing improper foot wear had 
Ischemic Ulcers and toe Gangrenes. Incidence of CAD, CVA, CKD and diabetes mellitus 
had  very high in outflow collaterals (even though the number was very low); that 
indirectly indicates the disease burden in these cases . This indirectly explains the poor 
survival and high complication rates in this group. 
 
                             CLI patients with respect to Ct Angiogram run off pattern  
 
 
Ct Angiogram run off Frequency Percent 
Single vessel 30 53.5 
 Double vessel 23 41.07 
 Triple vessel 3 5.3 
 Total 56 100.0 
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The incidence of CLI patients with single vessel runoff group are 53.5%, double 
vessel runoff group are41.07% and three vessels run off group is 5.3%. Even though the 
three vessels run off group appears to be having high patency rates and  no  reintervention 
rates, the p values were insignificant. This could be due to the very low number in three 
vessels run off group when compared to one and two vessels run off group. 
             Graft patency in relation to runoff 
 Numbers Patent Occluded Failing 
Single vessel run off 30 19 8 3 
Double vessel run off 23 20 1 2 
Triple vessel run off 03 2 0 1 
54% 41% 
5% 
CT Angiogram Run-off  
Single vessel  Double vessel  Triple vessel
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Type of Bypass in this series 
Femoro popliteal bypass forms the common form of bypass with 43 
patients.Among the above group, Femoro proximal popliteal artery bypass was done on 
24 patients, Femoro- mid Popliteal Artery surgery on 03 patients and Femoro distal 
popliteal artery bypass was done on 18 patients. Femoro posterior tibial bypass was 
performed in (n=05 patients).  Femoro anterior tibial bypass was performed in (n=02 
patients). Femoro -TP trunk bypass was done for 01 patient while popliteal to various 
distal arteries bypass was done for   03 patients.  
 
Type of Bypass Numbers (%) 
Femoral - Proximal Popliteal  Artery 24 42.8 
Femoral - Mid  Popliteal  Artery 03 5.3 
Femoral - Distal Popliteal  Artery 18 32.1 
Femoral - Anterior Tibial  Artery 02 3.5 
Femoral - Posterior Tibial Artery 05 8.9 
Femoral - TP Trunk 01 1.7 
Proximal Popliteal  to Distal PT 03 5.3 
Total 56  
44 
 
 
    Types of Bypass Surgery    
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Post procedure complications 
Complications Number of the patients % 
Wound infection 7 12.5 
Graft thrombosis 9 16.7 
Redo surgery 3 5.3 
Major amputations 3 5.3 
Minor  amputations 19 33.92 
Death 01 1.7 
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During the post operative follow up period one patient expired in the early 
postoperative period due to myocardial infarction. Primary patency rate of graft at the end 
of one year is 80 % (n=44) .Graft thrombosis rate in this study is 16.36% (n=9). Six  
grafts were  identified during their failing stage  in the study, out of which 3 patients 
underwent Redo bypass surgery (PAP 82.1%).Among redo group for 2 , grafts patency 
restored and their limbs salvaged  and 1 graft occluded subsequently and resulted in limb 
amputation .  
Nine grafts were occluded during the follow up period, out of which 2 patients 
presented with gangrenous stage beyond limb salvageable and underwent major 
amputation. Remaining graft occluded patients, were asymptomatic and they are under 
periodical observation. 
       Patients with wound infection in our series was 12.5% .Primary assisted 
patency rate in this study is 82.1 %. Limb salvage rate was 94.54%. Failing graft in this 
study is 10.9% ( n=6 ).   Major Amputation rate in this study is (5.3 %)       
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Types of Conduit 
Conduit used Total number (%) 
Reverse saphenous vein  43 76.7 
Composite graft(St.Marys Boot) 01 1.78 
Prosthetic graft ( PTFE) 12 21.4 
Total  56 100 
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Boot)
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Reversed saphenous vein was the most common conduit, used in 43 patients in our 
series. Synthetic  conduit like PTFE were used in 12 patients for supragenicular limb  
bypass, and Composite graft( PTFE  with St Marys Boot )  used in  01  patients to distal 
popliteal artery in whom the autogenous vein in both upper and lower limbs were of 
poor quality .  Li felong antiplatelet drugs and oral anticoagulation in selected group of 
patients (e.g., patient with grafts at high risk of thrombosis such as single vessel run off 
and in arteritis patients).  
 
Graft patency in relation to Type of Conduit 
 
         Conduit Patent Failing Occluded 
RGSV (N=43) 32 4  ( ASO=4, PT-2,AKB-2,SRO-3,DRO-
1) 
7 ( ASO=2,TAO=4,Arterits=1) 
PTFE  ( N=13) 9 2  ( ASO=2,DRO-1,TRO-1 ) 2 ( ASO=2) 
Total 41(73.2%) 6(10.7%) 9(16.07%) 
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            In our study group infra inguinal arterial bypass surgery, out of total 56 grafts, for 
43patients RGSV and 13 (1 = Composite graft) PTFE grafts used. Graft occlusion rate is 
16.07% and Graft failing rate is 10.7% in the study group. 
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The primary patency rate at end our study is 78.6 % (n=44 / 56) where  Duplex 
scan showed normal patent graft during the first visit. Among 44 patent grafts, RGSV 
were successful in 86.4%  and PTFE in 66.7% , which clearly  shows Vein graft have 
good patency rate than  synthetic grafts.  
 Failing grafts  detected  during study were 6,  three of them  underwent 
reintervention surgical procedures. No surgical reintervention performed for occluded 
grafts they were asymptomatic or not willing for surgery. 
Primary assisted patency – Graft Patency 
In the post operative study, 9 grafts out of 56 grafts (11.8%) were occluded in 
follow up period.  Six failing identified clinically, out of which 3 patients underwent 
revision procedure. In revision procedure, 1 got occluded and 2 grafts regained palpable 
pulses with limb salvage.  1 patient with no pulses subsequently underwent   AK 
amputation. The limb salvage rate in our study was relatively higher (n=53, 94.6%) 
compared to the graft patency (n=44, 78.6%) including the patients those were observed. 
The overall amputation in our study was 5.35 %( n=3), and the mortality rate in 
this study was 1.7 %.  
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Patency rates with respect to the number of outflow vessels  at  end of  12  months 
 
Variable One  vessel 
outflow 
Two  vessel 
outflow 
Three vessel 
outflow 
Number of  Grafts  30(53.5%) 23(41.07%) 03(5.3%) 
Primary patency rate 19 20 03 
Primary assisted patency (PAP) 1(occluded) 2(patent) 0 
Secondary patency rate N N N 
Cumulative patency rate 19(33.9%) 22(39.2%) 03(5.3%) 
 
 
 
Comparison of graft patency to that of etiology  
The graft patency was compared in relation to etiological factors in 56 patients. In 
atherosclerosis group of 38 grafts used , out them n=29  had patent grafts ,n=4 occluded 
and n=6 were failing .  In thromboangitis obliterans  n=11 were patent and n=4  were  
occuled .  In Arteritis group n=1 patent and n=1 occuled . TAO and arteritis had 
increased risk of graft occlusion during the follow up. 
 
52 
 
 
GRAFT  PATENT  FAILING  OCCLUDED 
ASO 29 6 4 
TAO 11 0 4 
Arteritis  1 0 1 
Total 41 6 9 
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Comparison of  graft patency  to that of bypass surgery(types) 
 
Type of Bypass NUMBERS PATENT FAILING OCCLUSION 
Femoral- Proximal 
Popliteal  Artery 
26 18 4 4 
Femoral-   Distal Popliteal  
Artery 
21 17           0 4 
Femoral-   Anterior Tibial  
Artery 
03 2 0 1 
Femoral-    Posterior Tibial 
Artery 
05 3 2 0 
Femoral-  TP Trunk 01 1 0 0 
Total 56 41 6 9 
 
The occurrence of graft stenosis or occlusion is more common in patients who 
underwent  infragenicular bypasses than above knee bypass. This could be due to the 
increased resistance and low flow state in peripheral arteries compared to that of central 
arteries. Three patients  had undergone AK amputation in the  post operative period 
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Limb salvage with respect to run off status 
 
  One  vessel 
outflow 
Two vessel 
outflow 
Three vessel 
outflow 
Number of 
limbs with CLI 
30(53.5%) 23(41.07%) 03(5.3%) 
Major 
amputation rate 
2(6.6%) 1(4.3%) 0 
Limb salvage 
rate  
28(93.3%) 22 (95.6%) 3/3(100%) 
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Outcomes 
 
                                            
Outcomes Frequency Percent 
 Limb Salvage 52 92.9 
  Amputation 3 5.4 
  Expired 1 1.8 
  Total 56 100.0 
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Outcome analysis in relation to etiology  
 
 
Outcomes  Etiology  
ASO TAO Arteritis 
Salvage 30 20 02 
Amputation 03 0 0 
Expired 01 0 0 
Total 34 20 2 
 
 
This high limb salvage rate when compared to the relatively low graft patency 
rates explains the collateral formation after bypass procedures especially when the graft 
was getting occluded gradually so that the limb survives. So these bypass procedures 
were considered as a bridge between critical limb ischemia period and collateral 
development so that limb ultimately survives 
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FACTORS   INFLEUNCING   GRAFT PATENCY  AND  LIMB  SALVAGE 
 
FACTO RS   PATENCY LIMB SALVAGE P value  
Gender Male 44 50 0.064 
Female 2 2 0.003 
Etiology ASO 31 35 0.295 
TAO 11 16 0.884 
Arterits 1 2 0.648 
Hyper coagulable 0 0 0000 
Redo Failing 2 2 0.431 
Occluded 1 1 0.548 
Outflow vessel Prox popliteal 22 23 0.312 
Mid popliteal 2 1 0.201 
Distal popliteal 15 19 0.452 
Anterior T ibial 2 3 0.326 
Posterior Tibial 3 5 0.147 
TP Trunk 1 1 0.576 
Level of surgery Above knee 
Bypass 
18 23 0.654 
Below knee 
Bypass 
22 29 0.496 
Conduit RGSV 33 40 0.468 
ePTFE 8 11 0.248 
Composite 1 1 0.491 
Graft Patency(1 
year) 
Primary 42 53 0.324 
PAP 44 52 0.510 
Cummulative 44 53 0.509 
Ct Angio Runoff Single 19 26 0.082 
Double 20 23 0.356 
Triple 3 3 0.567 
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DISCUSSION 
 
Infrainguinal bypass surgery in Chronic Limb Ischemia, is the mainstay of 
therapeutic modality aimed at limb salvage. The outcome of surgery is the chief 
determinant of limb salvage, affected by many factors. These factors can be modifiable 
factors and non modifiable factors. Since 1949, when Kunlin (4) introduced the 
femoropopliteal bypass graft with Saphenous Vein, several centers have reported their 
results(Patency rates at 30 days have varied from 76% to 96%1. which    is similar to this 
study. 
This was a prospective study involving 56 patients who had undergone femoro 
popliteal bypass. Primary aim of this study was to determine factors affecting the  graft 
patency .Mean age of the patient undergoing bypasses in this series was 51.7 yrs with 
range from 29to 74 yrs. Mean age of revascularization procedure in other series was 70 
yrs (2) (5). 
 In the study group of 56 patients, only 3 were female and the remaining patients 
were male(n=53) . In other series of lower limb revascularization there were female 
patients in the range of 20%2to 35% (3). The reason for this poor representation in the 
revascularization series might be due lower incidence of smoking in the females in our 
demography. Incidence of Thrombo Angiitis Obliterans(TAO) was higher in the males, 
whereas it has been only scarcely reported in females. Atherosclerotic Occlusive Disease 
is the  commonest  etiology  in this study (67.8%) compared to the literature which 
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quotes an etiology of  more than 95% .Thrombo Angiitis Obliterans (TAO)was almost 
non existent in their series  as compared to this study which showed an occurrence of  
28.5% remaining second most common etiology  in this series (2) (3).  Indians were more 
prone to Thrombo angiitis  obliterans because of the disease is  more common among the 
low socioeconomic peoples who smoke beedis which has an unprocessed tobacco in it. 
The prevalence is about 14%-50%. Arterial disease in the diabetic patients in Indian 
population has also been quoted at a lower rate of only 2%-4%.   
Smoking obviously forms a significant risk factor in the development of PAD as 
the incidence of smoking in this case series was 83.9 % and all were men. Incidence of 
CAD, CKD and diabetes mellitus was very high in patients with outflow via collaterals in 
CT Angiogram. In this study it was observed that diabetic mellitus does not adversely 
affect graft patency ( as referred in journals - Influence of diabetes & other factors on 
graft patency ( JVS ;August 2007)  (7) ; (8) .  
In this study  one case of Atrial myxoma presented with CLI , had undergone 
femoro-proximal popliteal  bypass  surgery  and graft was  patent compared with 
literature (18)  Vascular. 2005 Jul-Aug;13(4):222-9.In this review only 2 cases  were 
reported to have presented with CLI, as a  consequence of embolism due to atrial 
myxoma,  a rarity, treated successfully. 
Critical limb ischemia with minor or major tissue loss was the most common 
mode of presentation among the patients seeking  medical attention in this series which 
was about 78%, non healing ulcer in another 9% of the patients and critical limb ischemia 
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with rest pain in 11% . In other studies of Distal artery revascularization and gangrene 
was the mode of presentation in 32%- 44% (2) (5). (Eur J Surg 1994;160:17-25). 
Clinical examination, ankle brachial index during the postoperative period help in 
detecting the hemodynamically significant lesion and highlighting the need for graft 
surveillance, Color Doppler has shown a major difference in detecting the early failing 
grafts even in asymptomatic patients, which is similar to this study protocol as compared 
to that of the study done by Keith D Calligaro  and colleagues  (6). (Annals of vascular 
surgery -August 2001. 
The overall patency rate for Femoropopliteal  bypass using vein  and PTFE in this  
study is 86.4% and 66.7% respectively  when compared to other Literature  ( Patency rate 
for Femeropopliteal  bypass with vein  is  84 % and PTFE is  79 % both for proximal  and 
distal bypass- Review of results in infrainguinal bypass Dalman - 2000) (10 )  . Low 
patency rate for PTFE in this study is due to low sample (n=13) since, we mostly prefer 
autogenous vein for most of infrainguinal bypass surgery. 
The p values by Chi Square method for primary patency, Primary Assisted 
Patency (PAP) and cumulative patency rates with respect to the run off status at 1year 
were 0.324, 0.510 and 0.509 respectively and were statistically insignificant. In a study 
by Cvetanovski M. V., Jovev S. et al (12) , there was no significant difference in the graft 
patency rates between the groups concerning the lower limb tributaries and the runoff 
status. These results are in agreement with the results in a large number of studies, such 
as the study of  Martin et al. 
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Even though the three vessels run off group in this study appears to be having 
high patency rates and no reintervention rates, the p values (0.870) were insignificant. 
This could be due to the very low number (n=3) in three vessels run off group when 
compared to one and two vessels run off group. 
In our study the incidence of graft thrombosis in infrainguinal bypass for PTFE 
group (25.1%)    than the  vein group which is 20 %  and  is relatively similar   compared 
to other studies by Michael Belkin et al where they reported failure rate of 28.6% for  
synthetic   when compared to vein groups of 13.6% failure rate  (9). (Journal of vascular 
surgery ; February 1995 -Michael Belkin) In another study ,when Comparing Graft 
failure in this series was(n= 12 )(23.2%) patients within a total of 56 patients in the post 
operative period to the similar study by Tina R. Desai, et al in Infrainguinal Bypass , they 
found a primary  graft failure in 13% of their patients in  group of 351 patients of all 
revascularization  (1). James M. Seeger  et al reported forty-six graft failures occurred in 
45 patients (21.4%) in 210 patients who studied about the potential predictors of 
infrainguinal bypass surgery (13) 
In this study we used (n=1)   PTFE – Vein composite graft with interposition vein 
cuff (St.Marys Boot) which is patent and it is used to avoid compliance mismatch 
between the prosthetic graft and native artery, which was patent in post operative period . 
Prosthetic graft (PTFE) commonly used as an alternative to saphenous vein when  
autogenous vein is not available . PTFE graft is used  along with a vein cuff  improves 
the long term patency of the graft . Stonebridge et al in his randomized control study 
PTFE graft with vein cuff versus without cuff reported a 2 years patency of 52% versus 
29%. Clearly indicated when PTFE graft used for the below knee bypass surgery vein 
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cuff was recommended (20). Taylor patch was compare with St. Mary’s boot reported 
equivalent results.  
Post operative wound infection was in 7 % of the patients This low rate of wound 
infection was due to strict Theater Asepsis and preoperative antibiotics in all patients. 
The reported incidence of femoro popliteal graft infection in literatures was around 12% 
(11). In the study by Cvetanovski M. V., Jovev S. et al, the major amputation rates were 
4% (12) in comparision with our study it is n=3(5.4%). In the study by Cvetanovski M. V., 
Jovev S. et al, the mortality rate at 3rd month was 2% in comparision with our study it is 
n=1(1.78 %) who died of Myocardial Infarction .  
The rate of limb salvage in patients with failed grafts was 83.3% fo 1 year, when 
compared to literature (only 50% at 2 yrs after failure. - Midwestern vascular surgical 
society Chicago September 2003) (22) 
Postoperative mortality in the study was primarily caused by cardiac 
complications. This is not surprising considering the high incidence of coronary artery 
disease in patients with severe peripheral arterial occlusive disease (14) (Eur J Vasc 
Endovasc Surg 25:519–526, 2003). The mortality rate and the incidence of cardiac 
complications after primary amputation are at least as high or higher than after bypass 
grafting procedures, (15) and this is particularly true in patients with end-stage renal 
disease who undergo amputation (J Vasc Surg -1986;4:321-6) . 
Prospective randomized trial by Kretschmer et al found that long-term 
anticoagulation therapy with dicumoral improved femoropopliteal bypass graft patency 
rates primarily for patients who underwent arterial reconstruction for limb salvage (those 
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most likely to have poor runoff).Postoperative anticoagulation therapy with heparin and 
aspirin followed by long-term anticoagulation therapy with warfarin and aspirin were 
found to improve the duration of graft patency and the limb salvage rate after autogenous  
vein infrainguinal bypass grafting for patients at high risk for graft failure. (21) 
Anticoagulation therapy improves bypass graft patency and limb salvage in 
patients at high risk for infrainguinal bypass.In this study, selective patients with poor 
runoff and in few patients with TAO  had heparin in the post operative period and 
followed by oral anticoagulation with aspirin and their PT/INR was maintained at 2-2.5 
range.   
Statin therapy is associated with improved patency in infrainguinal vein graft by 
preventing stenosis and occlusion. It is also due to because of Atheroprotective , 
Antithrombotic & Antiinflammatory (independent effect) apart from lipid lowering  
effect.  (New England Society for vascular Surgery 2004 -Thomas a abbruzzese) (23)  In our 
study we have observed  less graft lesion   in infrainguinal  bypass  vein graft  who were   
on statins. 
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CONCLUSION 
 
• Infrainguinal revasularisation  surgery  has  acceptable  graft patency and survival rates. 
•  Graft patency rates were not adversely affected by poor runoff vessels, and when there 
was a reformation of the popliteal artery even when the out flow vessels were not 
adequately visualized angiographically. 
•  High limb salvage rates when compared to the relatively low graft patency rates explains 
the collateral formation after bypass procedures. 
• Femoro popliteal bypass grafting  is still treatment of choice where endovascular facilities 
available for  patients with disabling claudicants and in CLI especially with TASC C and 
D lesions. 
• Patients with poor conduit quality, active tobacco use and LV dysfunction have poorer 
clinical outcome 
• Graft surveillance is essential throughout the life to identify the failing graft and to 
intervene at appropriate time,to prolong the graft patency. 
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 PROFORMA 
 
 
NAME: __________________________ ADDRESS:______________ 
 
AGE: _____________SEX:_______OCCUPATION:___________________ 
 
CONTACT NO: _______________DATE OF DISCH: ________________ 
 
DIAGNOSIS 
1. 
2. 
 
TASC:          SEGMENT:     
 
HISTORY - Limb Upper / Lower    RT / LT / BL
Pain 
Claudication 
Claudication distance 
Rest pain 
Ulcer 
Discoloration 
Gangrene 
Swelling 
H/o injury 
 
RISK FACTORS/ ASSOCIATED CONDITIONS 
Smoking Yes/No Cig/bidi Years-____  Pack Years-_______ 
Alcohol 
Hypertension 
CAD 
CVA 
Diabetes 
APD 
TREATMENT HISTORY 
 
 
CLINICAL EXAMINATION 
Weight  Body Mass Index   BP -  
Lungs 
Heart 
Abdomen 
  
VASCULAR EXAM 
 
Peripheral Pulses     C B R F P DP PT 
  RT 
  LT 
LOCAL- RT/ LT: 
CVI 
Ulcers 
Gangrene 
Discoloration 
Edema/swelling/Motor weakness 
Ankle pressure  Brachial pressure  ABI 
RT 
LT 
DOPPLER STUDIES (Date -                   ) 
 Fem Pop DP  PT Br Rad Ul 
RT 
LT 
INVESTIGATIONS 
Hb        gm%  TLC               / cumm         DLC   
 
Lipid profile     TC  HDL  LDL  VLDL  TG 
ECG;        CAG        / Echo/    : EF-       %       LV Fn  RWMA 
 
X-Ray Chest 
 
Duplex Scan: Arterial/ Venous LL / UL      RT / LT 
 
DSA/ CT angio    Nature of the lesion: 
 
 Reformation of popliteal A:  AK/ BK segment.  
 
Status of the distal vessels: Number of vessels reformed up to the foot – named vessel/ 
collaterals.    
 
MANAGEMENT 
Medical/Surgical  DATE:  Anesthesia: GA / EA / SA / LA Surgeon: 
Operation: _____________________________________________________________ 
Procedure: Post op treatment: Inj.LMWH, T.ASA, T.Clopidogrel, Antibiotics, any other 
drugs according to the comorbidites. 
Post-op course:   
 
DISCHARGE STATUS 
 Ankle pressure Brachial pressure ABI 
RT/LT/Doppler signals over the graft:    
Discharge Advice: No smoking, T.ASA, T.Clopidogrel, other drugs prescribed by the 
cardiologist/ endocrinologist/ pulmonologist. 
Follow up: 
1/3/6/12 month: Date- 
Ankle pressure     Brachial pressure  ABI 
RT 
LT 
DOPPLER STUDIES / CDFI 
 Fem Pop DP  PT Br Rad Ul 
RT 
LT 
Requirement of secondary procedures like debridement with or without reconstruction/ 
amputation/ graft thrombectomy/ redo grafting…. 
Major events if any: 
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1 Subramani 50 1 1   Smoker;dyslip great toe gangren no flow    add hiatus; 
segmental
popliteal 1 mid sfa 1 2 1 1 2 0.9 3 2 1
2 Mukkammal 70 2 1 cad; arterits;dyslip Non healing ulcer no flow    add hiatus; 
segmental
post tibial 1 mid sfa 1 2 2 2 1 0.8 -2 1 1
3 Samson 50 1 2 smoker ulcer foot 0.7 distal sfa pta 2 prox sfa 3 1 1 1 2 1 3 2 1
4 Shankar 47 1 2 smoker 3rd toe gangrene 0.2 prox pop mid at 2 distal sfa 4 1 1 1 2 0.7 2 2 1
5 Rajendran 59 1 1 dm;Dyslipidemia 5 th toe gangrene no flow    add hiatus; 
segmental
prox pop 1 prox sfa 4 2 1 1 2 1 3 2 1
6 Kuppusamy 49 1 1 htn; smoker great toe gangrene 0.30 distal sfa mid pt 2 mid sfa 5 1 1 2 2 0.6 2 1 1
7 Govindasamy 59 1 1 dm; htn; smoker;dyslip great toe gangrene 0.3 add hiatus; 
segmental
distal pop 2 midsfa 3 2 1 1 2 0.6 2 2 1
8 Babu 41 1 2 smoker ulcer foot 0.2 sfa origin; 
segmental
midpop 2 cfa 3 1 1 1 2 1 3 2 1
9 Gopal 50 1 1 smoker;dyslip 0.45 add hiatus; 
segmental
prox pt 1 mid sfa 1 3 1 1 2 0.6 2 2 1
10 deena dayalan 65 1 1 dm;;dyslip 3rd toe gangrene no flow    add hiatus; 
segmental
prox pop 1 prox sfa 1 3 2 1 2 1 3 2 1
11 Duraisamy 52 1 1 smoker great toe gangrene 0.3 distal sfa mid pt 2 mid sfa 5 1 1 1 2 0.5 2 2 1
12 rajendran 56 1 1 smoker;ihd;dyslip ulcer leg 0.3 add hiatus; 
segmental
pta 2 mid sfa 5 1 1 1 2 0.6 -3 1 1
13 Perumal 57 1 1 dm; smoker;dyslip ulcer foot 0.4 sfa origin; 
segmental
prox pop 1 cfa 1 2 2 1 2 0.6 -1 1 1
14 ravikumar 46 1 2 smoker; toe gangrene noflow add hiatus; 
segmental
distal pop 2 cfa 3 1 1 3 2 0.7 -1 1 1
15 Rajavel 52 1 1 dm; htn; cva; smoker;dyslip ulcer heel 0.28 sfa origin; 
segmental
prox pop 1 cfa 1 1 1 1 2 0.5 2 2 1
16 Muthu 72 1 1 dm;;dyslip 3rd toe gangrene no flow    add hiatus; 
segmental
prox pop 1 prox sfa 1 2 2 3 2 0.5 -3 2 1
17 Krishnaiaha 52 1 1 smoker great toe gangren no flow    add hiatus; 
segmental
popliteal 1 mid sfa 1 2 2 1 2 0.9 3 2 1
18 Valliyammal 61 2 1 dm; htn; ihd;dyslip 0.35 cfa; segmental sfa; distal 
pop
1 cfa 1 1 1 1 2 0.45 2 1 3
19 Dayalan 52 1 1 smoker;dyslip great toe gangrene no flow    add hiatus; 
segmental
popliteal 1 mid sfa 1 1 1 1 2 0.7 3 2 1
20 Sudhakar 45 1 3 smoker great toe 0.5 midpop 
segmental
distalpop 2 distal sfa 3 1 3 1 2 0.6 2 1 1
21 Jayakumar 48 1 2 smoker 0.45 add hiatus; 
segmental
prox pt 1 mid sfa 5 2 1 1 2 0.6 2 2 1
22 Kuppan 65 1 1 smoker; dm;dyslip ulcer webspace 0.2 sfa origin prox pop 1 cfa 1 2 1 1 2 0.5 2 2 1
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23 Jayavel 65 1 1 smoker; dm ulcer webspace 0.2 sfa origin prox pop 1 cfa 1 2 1 2 1 no flow  -3 2 2
24 Babu 57 1 1 dm; htn ulcer foot 0.2 sfa origin; 
segmental
prox pop 1 cfa 1 1 1 1 2 0.5 1 2 1
25 Narasiaha 63 1 1 smoker 2nd toe gangrene 0.2 add hiatus pt 2 proxsfa 2 1 1 3 2 no flow  -3 2 2
26 Sakunthala 74 2 1 dm; htn; ihd 0.35 cfa; segmental sfa; distal 
pop
2 cfa 3 1 1 1 2 0.45 2 1 1
27 ravi 47 1 2 smoker; cad;dyslip ulcer toe tip 0.5 add hiatus; 
segmental
ant tibial 2 prox pop 4 1 1 3 2 0.7 2 2 1
28 Aliyaar 54 1 1 dm;smoker;dyslip 2nd toe gangrene no flow    add hiatus; 
segmental
prox pop 1 prox sfa 1 2 1 1 2 1 2 2 1
29 Ambedkar 38 1 2 smoker; gangrene 4 th toe 0.2 add hiatus prox pop 1 cfa 1 1 1 1 2 0.5 2 2 1
30 Jeganathan 65 1 1 smoker toes gangrene 0.3 mid pop; 
segmental
post  tibial 1 prox pop 1 2 2 1 2 0.7 2 2 1
31 Marimuthu 29 1 2 smoker great toe gangrene 0.2 add hiatus; 
segmental
midpop 2 mid sfa 3 1 1 3 2 0.6 2 1 1
32 Palanisamy 49 1 1  smoker; htn; Atrial 
myxoma;dyslip
ulcer heel 0.28
sfa origin; 
segmental
prox pop 1 cfa 1 2 2 1 2 0.5 2 2 1
33 Gopal 71 1 1 smoker; dm;dyslip gangrene 3 rd toe 0.2 sfa origin; 
segmental
prox pop 1 cfa 1 3 2 2 2 0.5 3 2 1
34 Anbu 35 1 2 smoker ulcer foot 0.3 add hiatus; 
segmental
prox pop 2 mid sfa 2 2 1 1 2 0.6 2 1 1
35 Subbaiha 72 1 1 smoker ulcer foot 0.2 sfa origin distal pop 2 cfa 3 1 1 1 2 0.8 2 2 1
36 Nagan 55 1 1 htn; smoker little toe gangren 0.25 add hiatus; 
segmental
tptrunk 2 mid sfa 5 1 1 2 2 1 3 2 1
37 Rajkumar 49 1 1 dm; htn ulcer foot 0.2 sfa origin distal pop 2 cfa 3 2 1 1 2 0.8 2 2 1
38 Venkatesaiha 50 1 1 dm toes gangrene 0.3 sfa origin prox pop 2 cfa 3 2 1 1 2 0.6 2 2 1
39 Rajendran 51 1 1 dm; htn; smoker great toe gangrene 0.4 add hiatus; 
segmental
distal pop 2 midsfa 3 2 1 1 2 0.6 2 2 1
40 Duraisamy 38 1 2 smoker ulcer foot 0.3 sfa origin; 
segmental
midpop 2 cfa 3 1 1 1 2 0.8 3 2 1
41 Arul 50 1 1 dm;smoker toes gangrene 0.25 sfa origin prox pop 2 cfa 3 2 1 1 2 0.6 2 2 1
42 Swaminathan 51 1 2 smoker great toe gangren 0.16 mid pop
no distal 
reformation
2 prox pop 5 1 1 1 2 0.6 2 2 1
43 Manohar 44 1 2 smoker great toe gangren no flow    add hiatus; 
segmental
popliteal 1 mid sfa 1 2 1 1 2 0.7 2 2 1
44 Balakrishnan 56 1 1 smoker;dyslip ulcer foot 0.5 distal sfa popliteal 1 prox sfa 1 3 2 1 2 1 3 2 1
45 Shankaran 51 1 1 dm;smoker 3rd toe gangrene no flow    add hiatus; 
segmental
prox pop 1 prox sfa 1 2 1 1 2 1 2 1 1
46 Chinnasamy 45 1 2 smoker great toe 0.5 midpop 
segmental
distalpop 2 distal sfa 3 1 1 1 2 0.7 2 2 1
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47 ganesan 65 1 1 dm;smoker;dyslip toes gangrene 0.25 sfa origin prox pop 2 cfa 3 2 1 1 2 0.6 2 2 1
48 Baskar 45 1 1 dm;smoker;dyslip ulcer foot 0.16 sfa origin prox pop 1 cfa 1 1 1 2 1 0.6 2 1 1
49 Selvam 48 1 2 smoker; gangrene 3 rd toe 0.2 add hiatus prox pop 1 cfa 1 2 2 1 2 0.5 2 2 1
50 Vadivelu 63 1 1 dm;smoker;dyslip 3rd toe gangrene no flow    add hiatus; 
segmental
prox pop 1 prox sfa 1 1 1 3 2 0.7 2 2 1
51 abdulla 63 1 1 smoker great toe gangrene 0.2 add hiatus pt 2 proxsfa 2 1 1 1 2 no flow  -3 2 2
52 kamaraj 46 1 2 smoker ulcer foot 0.4 midpop 
segmental
distalpop 2 distal sfa 3 1 1 1 2 0.7 2 2 1
53 Karunanidhi 36 1 3 smoker great toe gangren no flow    add hiatus; 
segmental
popliteal 2 mid sfa 3 1 1 3 2 0.9 3 2 1
54 Murugesan 55 1 1 htn; smoker little toe gangren 0.2 add hiatus; 
segmental
tptrunk 2 mid sfa 6 1 1 1 2 0.9 3 2 1
55 Soundarajan 61 1 1 dm; htn; smoker great toe gangrene 0.3 add hiatus; 
segmental
distal pop 1 midsfa 3 2 2 1 2 0.6 2 2 1
56 kumar 44 1 2 smoker; cad;dyslip ulcer toe tip 0.5 add hiatus; 
segmental
ant tibial 2 distal sfa 3 1 1 3 2 0.7 1 2 1
M=1 ASO=1 AKB=1
prox 
pop=1
single 
vessel=
1
RGSV
=1
Paten
t=1
PAP=
1
Yes=1
Yes=
1
F=2 TAO=2 BKB=2
distal 
pop=2
double 
vessel=
2
PTFE=
2
Faili
ng=2
No 
Redo
=2
No=2
No=
2
Arteritis
=3
midpop
=3
triple  
vessel=
3
Coposi
te=3
Occl
uded
=3
Expir
ed=3
mid 
at=4
mid 
pt=5
tptrunk
=6
OUTCOME ANALYSIS AND SURVEILLANCE OF  INFRA INGUINAL 
ARTERIAL BYPASS   GRAFT 
 
 
BACK GROUND 
In Crtical Limb Ischemia, Infrainguinal bypass surgery is the mainstay of therapeutic 
interventions aimed at limb salvage. The outcome of surgery is the chief determinant of limb 
salvage and is affected by multiple factors. The graft patency rates have been related to clinical 
severity of ischemia, distal run-off,patients risk factors, and Diabetes.  
This study is planned to review the factors that will influence the outcome of  
infrainguinal bypass  and to identify those factors that are modifiable, and  will help in 
improving the outcome of the procedures ,improve the patency of the graft and limb salvage rate.  
AIM 
 To assess early postoperative outcomes in patients undergoing Infrainguinal bypass 
surgery  ,to study the factors affecting the outcomes and to identify failing graft. 
METHODS AND MATERIALS 
 
It is Prospective study  in  56 patients from January 2010 to January 2012.Case records 
and angiograms of patients who underwent femoropopliteal bypass procedures. CLI and 
incapicitating  claudication is the main indication for surgery. Data pertaining to patient risk 
factors and co-morbidities were evaluated. CT angio  performed in all patients to assess the 
occlusive pattern, status of popliteal artery and run off status and the lesions were classified as 
per  TASC 2007 classification. Infrainguinal bypass surgery  were considered for all patients. 
Standard operative procedures were followed. Postoperatively all patients were given 
Plain Heparin or LMWH for 5 days & Tab. Aspirin 150mg OD & Tab. Clopidogrel 75mg and 
other drugs as per their co-morbidities. Graft surveillance was done by symptomatic analysis of 
rest pain status, palpable popliteal pulse and distal pulses, examination with handheld Doppler 
for signals and with Pre and post operative ABI. All patients were followed from the day of 
surgery to  the end of 12th month.Statistical analysis of the graft patency rates were calculated 
with respect to the CT Angio run off status,risk factors, etiolgical factors,and limb salvage rate.  
RESULTS 
In this study, most of the patients had presented at the age around 40 to 60 yrs. Smoking 
obviously forms a significant risk factor in the development of PAD as the incidence of smoking 
in this case series was 83.3%.Toe gangrene is commonest clinical presentation is58.9%.ASO is 
commonest etiology of 67.8%. Incidence of CAD, CKD and diabetes mellitus was very high in 
patients with outflow via collaterals. The incidence of CLI patients with single vessel runoff 
group are 53.5%, double vessel runoff group are 41.07% and three vessels run off group is 
5.3%.Among total of 56 patients, femoro popliteal bypass forms the common form of bypass 
with 43 patients compared to femoro distal bypass in other patients. Among various post 
operative complications minor amputations being 33.9% is the commonest complication. . 
Patients with wound infection in our series was 12.5%. 
During the post operative follow up period one patient expired in the early postoperative 
period due to myocardial infarction. In our study group infra inguinal arterial bypass surgery, out 
of total 56 grafts, for 43patients RGSV and 13 (1 = Composite graft) PTFE grafts used. Graft 
occlusion rate is 16.07% and Graft failing rate is 10.7%.Primary patency rate of graft at the end 
of one year is 80 % (n=44) .Graft thrombosis rate in this study is 16.36% (n=9). Six  grafts were  
identified during their failing stage  in the study, out of which 3 patients underwent Redo bypass 
surgery (PAP 82.1%).Among redo group for 2 , grafts patency restored and their limbs salvaged  
and 1 graft occluded subsequently and resulted in limb amputation .  
The p values for primary patency, cumulative patency rates with respect to the run off 
status at 12th month were 0.324, 0.509 respectively and were statistically insignificant.Primary 
assisted patency rate in this study is 82.1 %. Limb salvage rate was 94.54%. Failing graft in this 
study is 10.9% ( n=6 ).   Major Amputation rate in this study is (5.3 %).      
The graft patency was compared in relation to etiological factors in 56 patients. In 
atherosclerosis group of 38 grafts used , out them n=29  had patent grafts ,n=4 occluded and n=6 
were failing .  In thromboangitis obliterans  n=11 were patent and n=4  were  occuled .  In 
Arteritis group n=1 patent and n=1 occuled . TAO and arteritis had increased risk of graft 
occlusion during the follow up. The occurrence of graft stenosis or occlusion is more common in 
patients who underwent  infragenicular bypasses than above knee bypass. In this study  one case 
of Atrial myxoma presented with CLI , had undergone femoro-proximal popliteal  bypass  
surgery  and graft was  patent compared with literature (18)  Vascular. 2005 Jul-Aug;13(4):222-9. 
The rate of limb salvage in patients with failed grafts was 83.3% fo 1 year, when 
compared to literature (only 50% at 2 yrs after failure. - Midwestern vascular surgical society 
Chicago September 2003). 
 
CONCLUSION 
• Infrainguinal revasularisation  surgery  has  acceptable  graft patency and survival rates. 
•  Graft patency rates were not adversely affected by poor runoff vessels, and when there 
was a reformation of the popliteal artery even when the out flow vessels were not 
adequately visualized angiographically. 
•  High limb salvage rates when compared to the relatively low graft patency rates explains 
the collateral formation after bypass procedures. 
• Femoro popliteal bypass grafting  is still treatment of choice where endovascular facilities 
available for  patients with disabling claudicants and in CLI especially with TASC C and 
D lesions. 
• Patients with poor conduit quality, active tobacco use and LV dysfunction have poorer 
clinical outcome 
• Graft surveillance is essential throughout the life to identify the failing graft and to 
intervene at appropriate time,to prolong the graft patency. 
KEY WORDS 
Infrainguinal revasularisation, Graft surveillance, Graft patency,Conduit, CT angio,   
Primary Assited Patency. 
